Petros Pharmaceuticals Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $2.27 on 02/14/24, and the lowest price during the same period was recorded at $0.22 on 11/15/24.
52-week price history of PTPI Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Petros Pharmaceuticals Inc’s current trading price is -84.80% away from its 52-week high, while its distance from the 52-week low is 56.25%. The stock’s price range for this period has remained between $0.22 and $2.27. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.99 million for the day, which was noticeably lower compared to the shares’ average daily volume of 2.01 million over the last three months.
Financial Performance and Market Capitalization
Petros Pharmaceuticals Inc (PTPI) has experienced a quarterly decline of -17.35% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.46M and boasts a workforce of 21 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3355, with a change in price of -0.0129. Similarly, Petros Pharmaceuticals Inc recorded 1,299,302 in trading volume during the last 100 days, posting a change of -3.60%.
PTPI Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PTPI stands at 2.32. Similarly, the long-term debt-to-equity ratio is also 1.58.
PTPI Stock Stochastic Average
As of today, the raw stochastic average of Petros Pharmaceuticals Inc over the past 50 days is 28.94%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 20.16%. Additionally, the Stochastic %K and %D values for the company were 17.50% and 15.55%, respectively, over the past 20 days.
PTPI Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -12.41%. However, over the last six months, the performance has been stronger by -17.84%. The price of PTPI increased 10.54% over the last 30 days. And in the last five days, it has surged by 15.00%.
